Specifically, MUC16, an epithelial ovarian carcinoma antigen, is already used in clinics as a tool to diagnose ovarian cancer and it has been shown to predict lymph node metastasis with 0.78 sensitivity and specificity in EC [48]. Here, MUC16 is linked to ovarian cancer.